Abstract
Purpose: The study was aimed at the assessment of non-insulin-based markers as alternatives to the conventional insulin-based indices in anthropometry specified type 2 Diabetes mellitus. The outcome was targeted towards the utility of such indices in diabetes mellitus and associated metabolic derangements centering around insulin resistance. Methods: Fasting venous blood samples were utilized for biochemical analyses. The parameters included plasma glucose, insulin, lipid profile [triglycerides, HDL cholesterol, total cholesterol and LDL cholesterol (Friedewald equation)]. Uric acid, liver enzymes, renal profile, electrolytes, and thyroid function tests were also evaluated. Appropriate statistical analysis, as deemed fit for normal and skewed data were undertaken. Results: Across the BMI categories, significant differences were observed in several insulin-resistance indices. Quantitative Insulin Sensitivity Check Index (QUICKI) values were lowest in the obese group and highest in the normal-weight group ( p < 0.0001). Single Point Insulin Sensitivity Estimator (SPISE) values also showed reduction across normal, overweight, and obese groups ( p < 0.0001). The TyG index demonstrated a significant increase with rising BMI ( p = 0.0002). With reference to utility of SPISE as a predictor in anthropometry specified groups, it demonstrated a near-perfect discriminatory performance with an AUC of 0.99 (95% CI: 0.97–1.00, p < 0.0001). A cut-off value of < 5.55 yielded a sensitivity of 92.5% and specificity of 93.3%. Conclusions: SPISE, independent of insulin, showed high discrimination of BMI-defined obesity in this T2DM cohort, although its performance should be interpreted cautiously because BMI is incorporated into the SPISE equation.

This publication has 26 references indexed in Scilit: